Literature DB >> 4125349

Inhibitory effect of Australia-positive sera on in-vitro-stimulated T lymphocytes.

J Clot, O Mathieu, S Elharrar, M Robinet-Levy, J M Lemaire.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4125349     DOI: 10.1016/s0140-6736(73)92407-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.

Authors:  K Thestrup-Pedersen; K Ladefoged; P Andersen
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

2.  Properties of lymphocytes in chronic HBAg-positive hepatitis. An approach to pathogenetic problems.

Authors:  P Tolentino; M Pasino; A Braito; R Giacchino; A Astaldi
Journal:  Infection       Date:  1975       Impact factor: 3.553

3.  Immunological evaluation of asymptomatic carriers of hepatitis B virus.

Authors:  Y Levo; D Shouval; R Tur-Kaspa; S Wollner; S Penchas; A Zlotnick; M Eliakim
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

4.  Immune response to hepatitis B surface antigen.

Authors:  A B Ibrahim; G N Vyas; H A Perkins
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

5.  T-lymphocytes and hepatitis B serology.

Authors:  E Kaklamani; D Trichopoulos; G Papaevangelou; M Drouga; D Karalis; G Papoutsakis
Journal:  Infection       Date:  1978       Impact factor: 3.553

6.  Cell-mediated immunity in acute and chronic hepatitis.

Authors:  J R Wands; J L Perrotto; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

7.  Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.

Authors:  D S Nelson; J M Penrose; M F Waters; J M Pearson; M Nelson
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.